383 related articles for article (PubMed ID: 10405945)
1. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
Cibere J; Sibley JT; Haga M
J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
[TBL] [Abstract][Full Text] [Related]
3. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP
Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
[TBL] [Abstract][Full Text] [Related]
5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
6. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
[TBL] [Abstract][Full Text] [Related]
7. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
8. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment of NSAID-induced gastropathy.
Ament PW; Childers RS
Am Fam Physician; 1997 Mar; 55(4):1323-6, 1331-2. PubMed ID: 9092293
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and NSAID induced gastropathy.
Zeidler H
J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
[TBL] [Abstract][Full Text] [Related]
11. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
Agrawal NM; Aziz K
J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
[TBL] [Abstract][Full Text] [Related]
12. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug gastropathy.
Laine L
Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
[TBL] [Abstract][Full Text] [Related]
14. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
15. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
16. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
18. NSAID gastropathy. A new understanding.
Roth SH
Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
[TBL] [Abstract][Full Text] [Related]
19. The evolution of arthritis antiinflammatory care: where are we today?
Simon LS
J Rheumatol Suppl; 1999 Apr; 56():11-7. PubMed ID: 10225535
[TBL] [Abstract][Full Text] [Related]
20. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
